Biodexa Pharmaceuticals Plc (BDRX)

Biodexa Pharmaceuticals Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Feb 28, 2022	Dec 31, 2021
Cash & Equivalents	4.04	1.67	5.97	2.84	1.02	10.06
Cash & Short-Term Investments	4.04	1.67	5.97	2.84	1.02	10.06
Cash Growth	-20.16%	-72.05%	110.54%	178.59%	-89.88%	551.91%
Accounts Receivable	4.49	6.57	0.64	1.01	0.06	1.03
Other Current Assets	0.46	0.57	0.42	0.85	0.16	0.67
Total Current Assets	8.99	8.81	7.03	4.69	1.24	11.76
Net Property, Plant & Equipment	0.19	0.32	0.57	0.83	0.13	1.15
Other Intangible Assets	5.65	5.65	2.94	0.01	0.09	-
Total Assets	14.82	14.78	10.54	5.53	1.33	12.91
Accounts Payable	1.41	3.5	1.24	1.45	0.88	1.09
Short-Term Debt	0.5	0.61	0.17	0.16	-	0.15
Current Portion of Long-Term Debt	-	-	-	-	0.88	-
Other Current Liabilities	0.56	0.92	4.16	0.29	-	0.6
Total Current Liabilities	2.48	5.03	5.57	1.9	1.76	1.84
Long-Term Debt	-	0.12	0.3	0.46	0.24	0.62
Other Long-Term Liabilities	0.91	1.31	-	-	0.68	-
Total Long-Term Liabilities	0.91	1.42	0.3	0.46	0.7	0.62
Total Liabilities	3.39	6.46	5.86	2.36	2.46	2.46
Common Stock	13.94	11.73	6.25	1.11	16.15	1.1
Additional Paid-in Capital	-	-	143.19	137.39	6.53	137.16
Accumulated Other Comprehensive Income	-	-	-	-	0.11	-
Retained Earnings	-	-	-144.77	-135.34	-23.91	-127.8
Total Common Shareholders' Equity	13.94	11.73	4.68	3.16	-1.13	10.45
Shareholders' Equity	13.94	11.73	4.68	3.16	-1.13	10.45
Total Liabilities & Equity	17.32	18.18	10.54	5.53	1.33	12.91
Total Debt	0.5	0.73	0.46	0.62	1.12	0.77
Net Cash (Debt)	3.54	0.94	5.51	2.21	-0.1	9.29
Net Cash Growth	275.26%	-82.89%	148.96%	-	-	528.32%
Net Cash Per Share	2.22	1.90	174.35	4476.11	-278.73	23069.79
Book Value	13.94	11.73	4.68	3.16	-1.13	10.45
Book Value Per Share	8.74	23.67	148.11	6398.49	-3125.36	25952.58
Tangible Book Value	8.29	6.08	1.74	3.16	-1.22	10.45
Tangible Book Value Per Share	5.20	12.27	54.99	6386.35	-3384.47	25952.58

Updated Sep 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q